Abstract
The influence of an increasing dose of the vasopressin-like peptide DGAVP (desglycinamide-arginine-vasopressin) on memory was investigated in two groups of ten healthy male volunteers to provide information about the hypothesis of improvement of memory by vasopressin. At the same time we evaluated the effect of DGAVP on mood, alertness or sleepiness in a double-blind placebo-control design. The treatment group received at 9.15 a.m. intranasally a daily increasing dose from 0.1 mg at day 1 to 10.0 mg at day 5. DGAVP did not significantly affect any measure of memory or alertness. DGAVP did, however, produce a significant increase in concentration level and mood. The results of the present study provide no support for the vasopressin theory of memory improvement; rather, the results direct the attention to attention modulating effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beckwith B, Petros T, Kanaan-Beckwith S, Couk DI, Haug RG (1982) Vasopressin analogue (DDAVP) facilitates concept learning in human males. Peptides 3:627–630
Bohus B (1980) Effects of neuropeptides on adaptive autonomic processes. In: De Wied D, Van Keep PA (eds) Hormones and the Brain. MTP, Falcon House, England
Buschke H (1973) Selective reminding for analysis of memory and learning. J Verb Learn Verb Behav 12:543–548
De Diana IPF (1976) Two stochastic sleep quality scales for self rating of subject's sleep. Sleep Res 5:101
De Sonneville LMJ (1981) Ontwikkeling van de Amsterdamse Stemmingslijst (ASL). Doctoral thesis. Fl. 14-8-81 310 Department of Psychology, University of Amsterdam
De Sonneville LMJ, Schaap Th, Elshout JJ (1985) Ontwikkeling en validatie van de Amsterdamse Stemmingslijst. Gedrag-Tijdschrift voor Psychologie 13(1):13–19
De Wied D (1965) The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats. Int J Neuropharmacol 4:157–167
De Wied D (1984) The importance of vasopressin in memory. TINS 7:62–63
De Wied D, Bohus B, Van Wimersma Greidanus TjB (1975) Memory dificit in rats with hereditary diabetes insipidus. Brain Res 85:152–156
De Wied D, Van Wimersma Greidanus TjB, Bohus B, Urban I, Gispen WH (1976) Vasopressin and memory consolidation. Prog Brain Res 45:181–191
De Wied D, Gaffori O, Van Ree JM, De Jong W (1984) Central target for the behavioural effects of vasopressin neuropeptides. Nature 308:276–278
Duker H, Lienert GA (1959) Konzentrations Leistungs Test. Verlag für Psychologie, Göttingen Toronto Zürich
Fehm-Wolfsdorf G, Born J, Voigt J, Fehm HL (1984) Behavioural effects of vasopressin. Neurobiology 11:49–53
Gash DM, Thomas GJ (1983) What is the importance of vasopressin in memory pocesses? TINS 6:197–198
Gash DM, Thomas GJ (1984) Reply from Don M Gash and Garth J Thomas. TINS 7:64–65
Gilot P, Crabbe J, Legros JJ (1980) Bilan mnèsique de cinq sujets presentant un diabète insipide central idiopathique familial. Acta Psychiatr Belg 80:755–761
Gold W, Goodwin F, Ballenger J, Weingartner H, Robertson GL, Post RM (1980) Central vasopressin function in affective illness. In: De Wied D, Van Keep PK (eds) Hormones and the brain. MTP, Falcon House, England
Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC (1973) Quantification of sleepiness: a new approach. Psychophysiology 10:431–436
Jolles J, Gaillard AWK, Hijman R (1982) Memory disorders and vasopressin. In: Endroczi E, De Wied D, Angelucci L, Scapagnini U (eds) Integrative neurohumoral mechanisms. Elsevier/North-Holland, Amsterdam
Kovacs GL, Buijs RM, Bohus B, Van Wimersma Greidanus TjB (1982) Microinjection of arginine 8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats. Physiol Behav 28:45–48
Laczi F, Valkusz Z, Laszlo FA, Wagner A, Jardanhazy T, Szasz A, Szilard J, Telegdy G (1982) Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients. Psychoneuroendocrinol 7:185–193
Leshner AI, Hofstein R, Samuel P (1978) Intraventricular injection of antivasopressin blocks learned helplessness in rats. Pharmacol Biochem Behav 9:889–892
Pribram KH, McGuiness D (1975) Arousal, activation, and effort in the control of attention. Psychol Rev 82:116–149
Rigter H, Van Riezen H, De Wied (1974) The effects of ACTH and vasopressin-analogues on CO2-induced retrograde amnesia in rats. Physiol Behav 13(3):381–388
Strupp BJ, Levitsky DA (1985) A mnemonic role for vasopressin: the evidence for and against. Neurosci Biobehav Rev 9:399–411
Van der Ven AHGS (1966) De qualitatieve gegevens van de Bourdon-Wiersma Test. Ned T Psychol 21:364–366
Van Ree JM, Hijman R, Jolles J, De Wied D (1985) Vasopressin and related peptides: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry 9:551–559
Van Wimersma Greidanus TjB, De Wied D (1976) Dorsal hippocampus: site of action of neuropeptides on avoidance behavior? Pharmacol Biochem Behav [Suppl 5] 1:29–33
Waggoner RW jr, Slonim AE, Armstrong SH (1978) Improved psychological status of children under DDAVP therapy for central diabetes insipidus. Am J Psychiatry 35:361–363
Weingartner H, Gold P, Ballenger JC, Smallberg SA, Summers R, Rubinow D, Post RM, Goodwin FK (1981) Effects of vasopressin on human memory functions. Science 211:601–603
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snel, J., Taylor, J. & Wegman, M. Does DGAVP influence memory, attention and mood in young healthy men?. Psychopharmacology 92, 224–228 (1987). https://doi.org/10.1007/BF00177920
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00177920